2023 Vol.35 Issue 6
-
Preface to Special Issue: Cancer epidemiology, risk factors and screening
Binghe Xu, Hangcheng Xu
2023, 35(6): 563-564.
doi: 10.21147/j.issn.1000-9604.2023.06.01
-
Breast cancer: Epidemiology, risk factors and screening
Hangcheng Xu, Binghe Xu
2023, 35(6): 565-583.
doi: 10.21147/j.issn.1000-9604.2023.06.02
-
Challenge and future of cancer screening in China: Insights from esophageal cancer screening practice
Zhonghu He, Yang Ke
2023, 35(6): 584-594.
doi: 10.21147/j.issn.1000-9604.2023.06.03
-
Health economic evaluation on population-based Helicobacter pylori eradication and endoscopic screening for gastric cancer prevention
Zhiqiang Hu, Zongchao Liu, Wenqing Li, Weicheng You, Kaifeng Pan
2023, 35(6): 595-605.
doi: 10.21147/j.issn.1000-9604.2023.06.04
-
Epidemiology and early screening strategies for colorectal cancer in China
Yong Yang, Zhaoya Gao, An Huang, Jingyi Shi, Zhuang Sun, Haopeng Hong, Jin Gu
2023, 35(6): 606-617.
doi: 10.21147/j.issn.1000-9604.2023.06.05
-
Lung cancer burden and trends from 2000 to 2018 in China: Comparison between China and the United States
Yi Teng, Changfa Xia, Maomao Cao, Fan Yang, Xinxin Yan, Siyi He, Mengdi Cao, Shaoli Zhang, Qianru Li, Nuopei Tan, Jiachen Wang, Wanqing Chen
2023, 35(6): 618-626.
doi: 10.21147/j.issn.1000-9604.2023.06.06
-
Gastric cancer surgery in South Korea: Past, present, and future
Sung Gon Kim, Sang Eok Lee, Bang Wool Eom, Hong Man Yoon, Young-Woo Kim, Keun Won Ryu
2023, 35(6): 627-635.
doi: 10.21147/j.issn.1000-9604.2023.06.07
-
Benchmark for establishment of organoids from gastrointestinal epithelium and cancer based on available consumables and reagents
Ruixin Yang, Zhen Xiang, Ranlin Yan, Wingyan Kwan, Lu Zang, Zhenggang Zhu, Yao Qi, Yanping Xu, Xiaoyan Zhang, Hengjun Gao, Yingyan Yu
2023, 35(6): 636-644.
doi: 10.21147/j.issn.1000-9604.2023.06.08
-
Double-tract reconstruction is superior to esophagogastrostomy in controlling reflux esophagitis and enhancing quality of life after proximal gastrectomy: Results from a prospective randomized controlled clinical trial in China
Yinan Zhang, Hongtao Zhang, Yan Yan, Ke Ji, Ziyu Jia, Heli Yang, Biao Fan, Anqiang Wang, Xiaojiang Wu, Ji Zhang, Jiafu Ji, Xin Ji, Zhaode Bu
2023, 35(6): 645-659.
doi: 10.21147/j.issn.1000-9604.2023.06.09
-
Exploring ideal operative time for best outcomes in gastric cancer surgery: A multi-institutional study based on KLASS-07 database
Shin-Hoo Park, Ye-Rim Shin, Hoon Hur, Chang Min Lee, Jae Seok Min, Seung Wan Ryu, Hyun Dong Chae, Oh Jeong, Chang-In Choi, Kyo-Young Song, Ho Goon Kim, Ye Seob Jee, Kwang Hee Kim, Jeong Goo Kim, Kyung Sook Yang, Hua Huang, Sungsoo Park
2023, 35(6): 660-674.
doi: 10.21147/j.issn.1000-9604.2023.06.10
-
Estimation of economic burden throughout course of cervical squamous intraepithelial lesion and cervical cancer in China: A nationwide multicenter cross-sectional study
Hao Chen, Xuelian Zhao, Shangying Hu, Tingting You, Changfa Xia, Meng Gao, Mingjie Dong, Youlin Qiao, Fanghui Zhao
2023, 35(6): 675-685.
doi: 10.21147/j.issn.1000-9604.2023.06.11
-
Unveiling clinical significance and tumor immune landscape of CXCL12 in bladder cancer: Insights from multiple omics analysis
Zhouting Tuo, Dechao Feng, Zhiwei Jiang, Liangkuan Bi, Chao Yang, Qi Wang
2023, 35(6): 686-701.
doi: 10.21147/j.issn.1000-9604.2023.06.12
-
A multicenter study on efficacy of dual-target neoadjuvant therapy for HER2-positive breast cancer and a consistent analysis of efficacy evaluation of neoadjuvant therapy by Miller-Payne and RCB pathological evaluation systems (CSBrS-026)
Hongyu Xiang, Ling Xin, Jingming Ye, Ling Xu, Hong Zhang, Shuang Zhang, Yinhua Liu
2023, 35(6): 702-712.
doi: 10.21147/j.issn.1000-9604.2023.06.13